SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOSCHI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.615
EU - Europa 3.141
AS - Asia 1.875
SA - Sud America 32
OC - Oceania 20
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.573
IT - Italia 976
CN - Cina 838
PL - Polonia 577
SG - Singapore 487
UA - Ucraina 423
DE - Germania 331
GB - Regno Unito 280
TR - Turchia 259
FI - Finlandia 176
SE - Svezia 142
VN - Vietnam 84
ID - Indonesia 78
BE - Belgio 45
IN - India 45
CA - Canada 41
FR - Francia 36
AT - Austria 25
CZ - Repubblica Ceca 24
IR - Iran 23
RU - Federazione Russa 21
AU - Australia 20
CH - Svizzera 18
BG - Bulgaria 16
NL - Olanda 14
ZA - Sudafrica 12
BR - Brasile 11
HK - Hong Kong 10
JP - Giappone 10
LT - Lituania 10
TW - Taiwan 9
HU - Ungheria 8
MY - Malesia 8
AR - Argentina 7
CO - Colombia 5
ES - Italia 5
JO - Giordania 5
RO - Romania 5
PT - Portogallo 4
BO - Bolivia 3
CL - Cile 3
EG - Egitto 3
IQ - Iraq 3
PH - Filippine 3
PK - Pakistan 3
EC - Ecuador 2
EU - Europa 2
LB - Libano 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
DK - Danimarca 1
IE - Irlanda 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LI - Liechtenstein 1
MK - Macedonia 1
ML - Mali 1
MX - Messico 1
NP - Nepal 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 12.702
Salva come PNG Salva come JPEG
Città #
Woodbridge 845
Fairfield 782
Chandler 602
Warsaw 575
Houston 531
Santa Clara 531
Ann Arbor 511
Jacksonville 480
Ashburn 440
Singapore 383
Wilmington 301
Ferrara 297
Seattle 268
Cambridge 222
Nanjing 191
Izmir 179
Beijing 160
Addison 159
Princeton 144
Milan 120
Boardman 106
Dearborn 82
Dong Ket 81
Helsinki 78
Shanghai 78
Jakarta 70
San Diego 64
New York 62
Redwood City 57
Bremen 50
Los Angeles 49
Bologna 46
Nanchang 44
Shenyang 41
Brussels 40
Tianjin 33
Hebei 30
Changsha 28
London 25
Falls Church 24
Legnaro 24
Jiaxing 22
Kunming 22
Munich 22
Padova 22
Toronto 20
Brno 19
Vienna 19
Augusta 18
Chengdu 18
Frankfurt am Main 17
Monmouth Junction 17
Ningbo 17
Rome 17
Auburn Hills 16
Genova 16
Mountain View 16
Norwalk 16
Zurich 16
Des Moines 14
Ferrara di Monte Baldo 13
San Mateo 13
Washington 13
Taizhou 12
Jinan 11
Nuremberg 11
Wuhan 11
Hangzhou 10
Woking 10
Hong Kong 9
L’Aquila 9
Ottawa 9
Ardabil 8
Guangzhou 8
Kuala Lumpur 8
Leawood 8
Mumbai 8
Parma 8
Treviso 8
Orange 7
Turin 7
Verona 7
Ariano nel Polesine 6
Falkenstein 6
Lanzhou 6
Lappeenranta 6
Mcallen 6
Redmond 6
San Francisco 6
Tokyo 6
Varese 6
Zhengzhou 6
Florence 5
Fuzhou 5
Johannesburg 5
Maserà di Padova 5
Penicuik 5
Bogotá 4
Brescia 4
Bristol 4
Totale 9.482
Salva come PNG Salva come JPEG
Nome #
14 MeV neutrons for 99Mo/99mTc production: Experiments, simulations and perspectives 272
Therapeutic Radiometals: Worldwide Scientific Literature Trend Analysis (2008-2018) (vol 24, 640, 2019) 206
LARAMED: A Laboratory for Radioisotopes of Medical Interest 204
188Re(V) nitrido radiopharmaceuticals for radionuclide therapy 196
Biodistribution of nanostructured lipid carriers: a tomographic study 195
Preclinical SPECT-CT imaging studies with cyclotron produced Tc-99m 190
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 185
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals 183
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 157
A solvent-extraction module for cyclotron production of high-purity technetium-99m 154
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 152
E-learning as a tool to harmonize education and good quality assurance system in radiopharmacy 144
Therapeutic radiometals: Worldwide scientific literature trend analysis (2008–2018) 137
YAP-(S)PET small animal scanner: Quantitative results 136
Chemistry of the strong electrophilic metal fragment [99Tc(N)(PXP)]2+ (PXP = diphosphine ligand). A novel tool for the selective labeling of small molecules 129
Remotely controlled solvent extraction of high purity Tc-99m produced by conventional medical cyclotrons 129
Therapeutic Radiometals: Global Trends Analysis of Scientific Literature (2008 -2018) 129
Geometrically controlled selective formation of nitrido technetium(V) asymmetrical heterocomplexes with bidentate ligands 129
A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma 127
Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma 126
In-house cyclotron production of high-purity Tc-99m and Tc-99m radiopharmaceuticals 126
An alternative approach to the preparation of (188)Re radiopharmaceuticals from generator-produced [(188)ReO(4)]:(-) efficient synthesis of (188)Re(V)-meso-2,3-dimercaptosuccinic acid 124
A new solvent-extraction module for a local routine production of technetium-99m by medical cyclotrons 124
A novel approach to the high-specific-activity labeling of small peptides with the technetium-99m fragment [Tc-99m(N) (PXP)](2+) (PXP = diphosphine ligand) 124
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 123
Synthesis of a novel class of nitrido Tc-99m radiopharmaceuticals with phosphino-thiol ligands showing transient heart uptake 123
Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons 123
Design and synthesis of a redox-active Tc-99m radiopharmaceutical with ferrocenedithiocarboxylate [FcCS = Fe(C5H4CS2)(C5H5)-]. 122
Influence of the Generator in-Growth Time on the Final Radiochemical Purity and Stability of Radiopharmaceuticals 121
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 120
Radiofarmaci marcati con altri radionuclidi (Indio-111, Rame-64, Iodio-124, Zirconio-89) 119
Whole-Body Biodistribution and Radiation Dosimetry of the New Cardiac Tracer 99mTc-N-DBODC 118
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy 118
Interdisciplinary tasks in the cyclotron production of radiometals for medical applications. The case of 47Sc as example 116
Labeling of Fatty Acid Ligands with the Strong Electrophilic Metal Fragment [99mTc(N)(PNP)]2+ (PNP=Diphosphane Ligand) 112
Radiochemical purity and stability of 99mTc-HMPAO preparations:the influence of pH, volume recovery, and storage conditions 111
null 111
The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)](2+) metal fragments (M = Tc, Re; PXP = diphosphine ligand) 110
Radioisotopic purity and imaging properties of cyclotron-produced 99mTc using direct100Mo(p,2n) reaction 110
null 109
Produzione e verifiche di qualità dei radiofarmaci prodotti mediante kit 108
Radiochemical purity and stability of 99mTc-HMPAO in routine preparations 108
Development of an Automatic Separation/Extraction Module for the Accelerator 99mTc Production from 100Mo-Enriched Molybdenum Metal Targets 106
Technetium and rhenium heterocomplexes containing the diphenylphosphinoferrocenyl fragment 105
Development of a β-spectrometer Based on TDCR Method for 99gTc Activity Estimations 105
Technetium-99m nitrido radiopharmaceuticals with unprecedented biological properties 103
null 102
Synthesis, solution-state and solid-state structural characterization of monocationic nitrido heterocomplexes [M(N)(DTC(PNP)](+) (M=Tc-99, Re; DTC = dithiocarbamate; PNP = heterodiphosphane) 100
null 98
PEGylated N-methyl-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of nitrido Tc-99m and Re-188 radiopharmaceuticals 98
The emerging role of copper-64 radiopharmaceuticals as cancer theranostics 98
Safety profile, biodistribution and dosimetry of the new myocardial perfusion imaging agent [99mTc]N.DBODC: first evaluation in Human. 96
Erratum: A kit formulation for the preparation of 188Re- lipiodol: Preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma (Nuclear Medicine Communication (2004) 25 (691-699)) 95
First Accelerator-Based 99mTc GBq Production Levels and in-vivo Imaging Tests for APOTEMA Experiment 92
Extraction techniques of 99mTc from 100Mo Metal Target 91
Automated synthesis of 68Ga-DOTA-TOC with a cationic purification system: Evaluation of methodological and technical aspects in routine preparations 91
Technetium complexes and radiopharmaceuticals with scorpionate ligands 91
A Study on the Gamma-Ray Background of the Images Obtained Using Accelerator- Produced 99mTc 89
First evaluation in humans of the new myocardial perfusion imaging agent 99mTcN-dbodc: safety, biodistribution and dosimetry assessment 88
Symmetric bis-substituted and asymmetric mono-substituted nitridotechnetium complexes with heterofunctionalized phosphinothiolate ligands 88
A CD4/T4 receptor peptide ligand labeled with technetium-99m: Synthesis and biological activity 86
Development of new 99mTc-labeled bisphosphonates for bone scintigraphy 85
Comprehensive theoretical investigation of the accelerator-produced 99mTc: determination of post-EOB evolution of quality parameters 84
Recovery of Molybdenum Precursor Material in the Cyclotron-Based Technetium-99m Production Cycle 84
Perspectives on the use of liquid extraction for radioisotope purification 83
Development of a β-spectrometer for 99gTc Activity Estimations 83
The IART approach: new Re-188 nitrido biotinilated radiopharmaceuticals useful for cancer therapy 82
null 82
Production of 47Sc with natural vanadium targets: results of the PASTA project 81
null 80
Rhenium(V) and Technetium(V) Nitrido Complexes with Mixed 2 Tridentate pigreco-Donor and Monodentate pigreco-Acceptor Ligands 79
CYCLOTRON-BASED ALTERNATIVE PRODUCTION OF 99mTc: INFN RESEARCH ACTIVITIES 79
Asymmetrical nitrido Tc-99m heterocomplexes: A class of cardiac agents with unprecedented imaging properties. 76
Radiochemical Puritiy Of 99mTc-HMPAO: some Considerations on Routine Radiopharmaceuticals Preparation 76
188W/188Re generator system and its therapeutic applicacions 76
Oxo-rhenium(V) mixed-ligand complexes with bidentate functionalized phosphines and tridentate Schiff base ligands 76
Synthesis and biologic evaluation of monocationic asymmetric 99mTc-nitride heterocomplexes showing high heart uptake and improved imaging properties 75
Synthesis of a novel class of trigonal bipyramidal nitrido Tc(V) complexes with phosphino-thiol ligands. Crystal structure of [Tc-99g(N)(L-1)(2)] [L-1=2-(diphenylphosphino)ethanethiolato] and [Tc-99g(N)(L-5)(2)] [L5=2-(ditolylphosphino)propanethiolato] 75
Synthesis and labelling with the [99mTcN]2+ core of macromolecular multifunctional ligands for sentinel limphnode detection 73
LARAMED: a LAboratoty of RAdioisotopes for MEDicine 73
A class of asymmetrical nitrido Tc-99m heterocomplexes as heart imaging agents with improved biological properties 73
Quality control of Tc-99m radiopharmaceuticals: influence of the generator in growth time on the final radiochemical purity 72
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 72
New "3+1" chelating system for the development of therapeutic agents labeled with rhenium-188 70
An alternative method to produce isotopes for medical applications in the framework of the SPES Project: Mo-99 from the UCx target 69
A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons 69
Radioactive metal complexes comprising a tridentate complexing sequence 69
Efficient preparation and stabilization of Re-188-MDP under physiological conditions 68
Synthesis and biological evaluation of a novel 99m Tc -Nitrido Labeled Substance P Derivative 68
Worldwide ten-year trend analysis of the scientific literature on therapeutic radiometals (2008-2018) 68
Might Re-188 be more effective for boosting therapy of breast cancer using the IART approach? 67
The [Tc-99m(N)(PNP)](2+) metal fragment: A technetium-nitrido synthon for use with biologically active molecules the N-(2-methoxyphenyl)piperazyl-cysteine analogues as examples 67
Brain slices as an experimental model for studying the effects of metabolic alterations on the brain retention of perfusion tracers 66
PEGylated N-methly-S-methyl dithiocarbazate as a new reagent for the high-yield preparation of Nitrido99mTc and 188Re radiopharmaceuticals 66
The Tc-99m fragment [Tc-99m(N)(PXP)](2+): A novel tool for high-specific-activity labeling of biomolecules. 65
New [3+1] Chelating System for Rhenium (V) Nitrido Radiopharmaceuticals 65
A picture of modern Tc-99m radiopharmaceuticals: Production, chemistry, and applications in molecular imaging 65
Radiopharmacy/Radiochemistry for Conventional Single-Photon Emitting and Therapeutic Radiopharmaceuticals 65
First Application of the IART Approach with a new Re-188 Labeled Biotin-Derivative 65
Biodistribution in rats of bone-seeking Re188 complexes obtained under different labelling conditions 64
Totale 10.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.473
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.993
Totale 74.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.044 0 0 0 0 0 0 257 221 186 242 90 48
2020/20212.084 147 118 153 176 111 174 113 290 94 305 244 159
2021/20221.597 71 118 103 75 66 67 83 92 73 125 245 479
2022/20231.485 167 142 43 183 221 197 99 115 140 25 93 60
2023/20241.073 76 97 100 46 72 134 76 74 33 42 51 272
2024/20251.592 126 115 340 195 484 324 8 0 0 0 0 0
Totale 13.035